SureTrader SureTrader
Home > Boards > US OTC > Delisted >

GFR Pharmaceuticals, Inc. (fka GFRP)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 8/26/2016 9:39:40 AM - Followers: 3 - Board type: Free - Posts Today: 0

  THE DISCUSSION BOARD FOR

GFRP, Hua Long, New Century and Baosai are hereinafter referred to as (the “Company”).

GFRP, i.e. New Century, formerly Shan Xi New Century Technology Investment Development Company Ltd., provides consulting services for chemical technology investment, investment and management of technical project, natural extract, development, production and sales of purification chemicals (except food, medicine, danger goods, poisonous production), research, production and sales of chemical facility, agent service (except sales of medicine and medical facilities), commercial consulting services and property management. With the extensive cooperative relationships with the leading hospitals in China, New Century also provides therapy equipment and the comprehensive service to cancer patients. Presently, the company has four sets of high-end medical facilities, including MASEP SSRS gamma rays stereotactic radiation therapy systems for heads, our gamma rays stereotactic radiation therapy system Philips pet system and Canadian cyclotron system. New Century also has a a professional medical website to offer comprehensive online consultation and three service centers for body check and medical treatment. Up till now, New Century has grown to be the largest medical facility management company in Shan Xi province. In the future, it will dedicate its resources to expanding market share and investment in a tumor therapy center or hospital with a modernized tumor institute. In the coming three years, they expect to be a well-known cancer institute in west China.

 

 
The Company’s business units have been aggregated into two reportable segments, as defined by SFAS 131:
 
·
Medical Business - joint operation of PET Scanner and Rotary Gamma Ray Stereotactic Neurosurgery System imaging center in the PRC.
 
·
Extraction Business - extraction of raw materials to medicine ingredients and distribution of extracted ingredients for medicine manufacturing uses.
 

SHARE STRUCTURE:

O/S 42,079,940 (this figure has been the same for 1 1/2 years.)

- Book value .16/share. http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=6107248

- EPS for the 3 months ending June 30th was .02/share.

 

ORGANIZATION AND BUSINESS BACKGROUND : GFR PHARMACEUTICALS, Inc. (GFRP)

GFR Pharmaceuticals, Inc. (the “Company” or “GFRP”) was incorporated in the State of Nevada on December 18, 1996 as Laredo Investment Corp. On August 9, 2004, Laredo Investment Corp. changed its name to GFR Pharmaceuticals, Inc.

 
The Company, through its subsidiaries, mainly engages in a joint operation of a Positive Emission Tomography (“PET”) Scanner and Rotary Gamma Ray Stereotactic Neurosurgery System imaging center in Xian City, Shaanxi Province, the People’s Republic of China (the “PRC”) .  

 
Xi’an Hua Long Yu Tian Ke Ji Shi Ye Co., Ltd. (“Hua Long”) is a wholly-owned subsidiary of the Company, which was incorporated as a limited liability company in the PRC on December 23, 1999. Its principal activity is an investment holding of 95% equity interest in New Century Scientific Investment Ltd. (“New Century”).

 
New Century was incorporated as a limited liability company in the PRC on November 23, 2001 with a registered capital of RMB30,000,000 (equivalent to US$3,636,000). It jointly operates a PET Scanner and Rotary Gamma Ray Stereotactic Neurosurgery System imaging center with Tong Du Hospital ( " the Hospital " ) in Xian City, Shaanxi Province, the PRC. The duration of the operation was 11 years and it will expire in 2017.

 
On May 14, 2008, the Company completed the acquisition of assets and liabilities of Xi’an Jiaoda Bao Sai Bio-Technology Co., Ltd ("Bao Sai") pursuant to the terms of a Stock Purchase Agreement dated January 1, 2008, between GFRP and Bao Sai. The consideration was $4,500,211 (approximately RMB33,000,000) for 96.77% of its equity interest in Bao Sai, based on the aggregate net book value of total assets and liabilities of Bao Sai as of December 31, 2007. The closing date was January 1, 2008. Upon the completion of the transaction, Bao Sai became a subsidiary of the Company.

 
GFRP, Hua Long, New Century and Baosai are hereinafter referred to as (the “Company”).

GFRP, i.e. New Century, formerly Shan Xi New Century Technology Investment Development Company Ltd., provides consulting services for chemical technology investment, investment and management of technical project, natural extract, development, production and sales of purification chemicals (except food, medicine, danger goods, poisonous production), research, production and sales of chemical facility, agent service (except sales of medicine and medical facilities), commercial consulting services and property management. With the extensive cooperative relationships with the leading hospitals in China, New Century also provides therapy equipment and the comprehensive service to cancer patients. Presently, the company has four sets of high-end medical facilities, including MASEP SSRS gamma rays stereotactic radiation therapy systems for heads, our gamma rays stereotactic radiation therapy system Philips pet system and Canadian cyclotron system. New Century also has a a professional medical website to offer comprehensive online consultation and three service centers for body check and medical treatment. Up till now, New Century has grown to be the largest medical facility management company in Shan Xi province. In the future, it will dedicate its resources to expanding market share and investment in a tumor therapy center or hospital with a modernized tumor institute. In the coming three years, they expect to be a well-known cancer institute in west China.

SHARE STRUCTURE:

O/S 42,079,940 (this figure has been the same for 1 1/2 years.)

- Book value .16/share. http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=6107248

- EPS for the 3 months ending June 30th was .02/share.

- We recorded revenues of $1,539,313 and $2,221,720 for the three and six months ended June 30, 2008, respectively. New Century owns radiology and oncology equipment and provides it to Tangdu Hospital’s Gamma Knife Therapeutic Center (the “Center”) in Shan Xi province, which is affiliated with the Fourth Military Medical University. New Century currently owns three different devices used for radiological imaging for the brain and body and cancer treatment. For the six months ended June 30, 2008, the Center averaged approximately 188 cases per month as opposed to 204 cases per month in 2007. New Century receives a percentage of profits from the Center.

- Our net income was $715,907 and $864,885 for the three and six months ended June 30, 2008, an increase of $248,083 and $467,570, or 53% and 118%, respectively, as compared to net income for the same period ended June 30, 2007. Such increase was due primarily to the increase in revenues covering the operating expenses in these periods

http://www.gfrpharma.com/gfr6.html

 


 

PostSubject
#41   GFRP revoked: Renee 08/26/16 09:39:39 AM
#40   GFRP SEC Suspension for Financials / Filings delinquencies: Renee 05/20/16 09:36:05 AM
#39   GFRP is smells like a winner kranthikumar 05/05/14 09:52:33 AM
#38   No idea, wish I still owned it !!! pmunch 12/09/11 01:46:30 PM
#37   how did it get to $.74? IPO$ 12/09/11 01:33:43 PM
#36   Check now ... pmunch 02/10/10 09:08:57 AM
#35   Nice volume here, moving up !!! pmunch 02/01/10 11:07:32 AM
#34   The chromatograph market worldwide is 5 billion dollars. IPO$ 10/01/09 05:13:51 PM
#33   sitting 4 cents on bid is a shame.....with IPO$ 10/01/09 05:13:16 PM
#32   These leading brands include: IPO$ 10/01/09 05:12:46 PM
#31   I belioeve they hold the market monopoly for IPO$ 10/01/09 05:12:31 PM
#30   ots profits were generated from their PET and IPO$ 10/01/09 05:11:09 PM
#29   they must have evolved over the years... IPO$ 10/01/09 05:10:29 PM
#28   2 core businesses, 1 PET scanner,Gamma Knife at pmunch 10/01/09 05:08:53 PM
#27   what kind of business do they have in IPO$ 10/01/09 04:53:32 PM
#26   It is tightly held ...hope she rises pmunch 10/01/09 04:45:51 PM
#25   This is a Chinese stock that has been IPO$ 10/01/09 03:07:30 PM
#24   Revenues pmunch 08/21/09 12:35:29 PM
#23   Someone buying up shares, trying to not sound pmunch 08/21/09 12:32:51 PM
#22   http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6470407 pmunch 08/21/09 12:32:26 PM
#21   Quarterly/Yearly report Filed .. pmunch 08/21/09 12:31:09 PM
#20   Update Quarterly Report Filed ... pmunch 05/14/09 10:58:08 AM
#19   42 million shares, tightly held ... Overseas company pmunch 04/28/09 01:05:01 PM
#18   GFRP picked up the dreaded "E" today... dc_350 04/20/09 08:20:31 AM
#17   On January 5, 2009, the Company engaged Yu pmunch 03/25/09 12:43:35 PM
#16   :-d dc_350 03/25/09 12:32:35 PM
#15   YES, we are in demand !!!! pmunch 03/25/09 12:24:05 PM
#14   Ok, who's got the paintbrush...lol dc_350 03/25/09 11:26:49 AM
#13   Looks like someone got tired of holding...20K just sold... dc_350 02/19/09 10:16:47 AM
#12   New Auditor engaged, maybe time for an uplist pmunch 01/23/09 08:28:38 AM
#11   New Financials Look AWESOME pmunch 11/24/08 10:50:58 AM
#10   Financials look awesome ... http://finance.yahoo.com/q/is?s=gfrp.ob pmunch 10/30/08 10:36:33 AM
#9   picked up some cheapies today !!! pmunch 10/20/08 03:41:27 PM
#8   no, Canada pmunch 10/15/08 01:21:49 PM
#7   Aren't they located in China? IPO$ 10/15/08 11:40:34 AM
#6   Supernatural British Columbia Home to GFR Pharma pmunch 10/14/08 05:02:03 PM
#5   Meet the GFR Professionals pmunch 10/14/08 04:57:18 PM
#4   GFR Commitment to Quality Assurance pmunch 10/14/08 04:50:13 PM
#3   About GFR Pharma pmunch 10/14/08 04:47:13 PM
#2   in ... pmunch 10/10/08 06:22:33 PM
#1   1st post to this lonely site! IPO$ 01/07/08 02:34:46 PM
PostSubject